Safeguard Insights

November 20, 2013

PaaS vendor Apprenda gets boost with $16M Series C financing

For sixty years, Safeguard has been supporting entrepreneurs and funding innovations that have had a transformative impact on our lives. Today, we continued that tradition…

Posted by Philip D. Moyer

April 6, 2012

Week in Review: Strong First Quarter for IPOs, JOBS Act Becomes Law

The first quarter of 2012 has come and gone, leaving positive signs for venture capitalists. Twenty venture-backed start-ups made their IPO in the past three…

Posted by John E. Shave III

March 30, 2012

Q&A: Jean Hoffman, CEO, Putney – “Entrepreneurs are Problem Solvers”

For the next installment of our partner company Q&A series, we turn to the life sciences side of our portfolio and interviewed Jean Hoffman, Founder,…

Posted by Peter J. Boni

February 29, 2012

Q&A: Rich Milgram, CEO, Beyond.com – “Persistence and Patience are Key” to Success

This year, we launched a Q&A Series with our partner company CEOs to provide insight, lessons learned and  first-hand knowledge about what it takes to…

Posted by Peter J. Boni

January 27, 2012

Week in Review: Venture Investment Grew 22% YoY; Alverix and The Doctors; Beyond.com Among Future 50; MediaMath on FoxBusiness

Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…

Posted by John E. Shave III

December 22, 2011

Big Data and Gamification: How These Trends Drive Innovative Solutions

Earlier today we announced that Safeguard Scientifics added two new technology partner companies to its portfolio: Crimson Informatics and Hoopla Software. Big data, mobile, cloud…

Posted by Philip D. Moyer

December 6, 2011

3 Tips on Valuations and Exits for Emerging Healthcare Companies

Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…

Posted by James A. Datin

December 1, 2011

Defining Safeguard Scientifics: Not Venture Capital. Not Private Equity. And More than Just Capital.

Here at Safeguard Scientifics, we provide capital to growth-stage companies in both the life sciences and technology. It’s important to note, however, that Safeguard provides…

Posted by John E. Shave III

November 23, 2011

A Focus on Life Sciences

Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…

Posted by James A. Datin

Content